Description

Actrapid (insulin) NM solution for injections 100 IU/ml. 10 ml. vial №1

Ingredients

Actrapid (insulin) NM solution for injections contains 100 IU/ml of insulin as the active ingredient. Other ingredients may include sodium chloride, hydrochloric acid, and sodium hydroxide.

Dosage

The dosage of Actrapid (insulin) NM solution for injections should be individualized based on the patient’s needs. It is typically administered subcutaneously, and the dosage may vary depending on factors such as blood glucose levels and meal times.

Indications

Actrapid (insulin) NM solution for injections is indicated for the treatment of diabetes mellitus to help control blood sugar levels. It is used in both type 1 and type 2 diabetes.

Contraindications

Actrapid (insulin) NM solution for injections is contraindicated in patients with hypersensitivity to insulin or any of the ingredients in the formulation. It should not be used during episodes of hypoglycemia.

Directions

Actrapid (insulin) NM solution for injections should be administered as directed by a healthcare provider. It is important to follow the prescribed dosage and injection technique to ensure proper absorption and effectiveness.

Scientific Evidence

Actrapid (insulin) NM solution for injections has been extensively studied in clinical trials and has shown efficacy in controlling blood glucose levels in patients with diabetes. Research published in the Journal of Clinical Endocrinology & Metabolism demonstrated the effectiveness of Actrapid in improving glycemic control.

Additional Information

Actrapid (insulin) NM solution for injections is a fast-acting insulin that helps lower blood sugar levels quickly after administration. It is important to monitor blood glucose levels regularly while using this medication to adjust the dosage as needed.

Pharmacologically, Actrapid works by promoting the uptake of glucose into cells, thereby reducing blood sugar levels. It mimics the action of naturally produced insulin in the body, helping to regulate glucose metabolism.

Clinical studies have shown that Actrapid is comparable in effectiveness to other short-acting insulins in controlling postprandial glucose levels. Its rapid onset of action makes it a valuable treatment option for managing blood sugar spikes.